Possible Worldwide Impact of Prevention of Human Papillomavirus Infection

The Papillomaviruses

Volumn , Issue , 2007, Pages 387-413

  Pagliusi, Sonia R ^a   Aguado, M Teresa ^a   Parkin, D Maxwell ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 53449099115     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-36523-7_16     Document Type: Chapter

References (107)

1. Allen, M., Kalantari, M., Ylitalo, N., Pettersson, B., Hagmar, B., Scheibenpflug, L., Johansson, B., Petterson, U., and Gyllensten, U. (1996). HLA DQ-DR haplotype and susceptibility to cervical carcinoma: Indications of increased risk for development of cervical carcinoma in individuals infected with HPV 18. Tissue Antigens 48:32-37.
2. Astori, G., Lavergne, D., Benton, C., Hockmayr, B., Egawa, K., Garbe, C., and De Villiers, E. M. (1998, May). Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J. Invest. Dermatol. 110(5):752-755.
3. Bayo, S., Bosch, F. X., De Sanjose, S., Munoz, N., Combita, A. L., Coursaget, P., Diaz, M., Dolo, A., Van Den Brule, A. J., and Meijer, C. J. (2002, Feb). Risk factors of invasive cervical cancer in Mali. Int. J. Epidemiol. 31(1):202-209.
4. Bauer, H. M., Ting, Y., Greer, C. E., Chambers, J. C., Tashiro, C. J., Chimera, J., Reingold, A., and Manos, M. M. (1991, Jan). Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 265(4):472-477 (See also pages 23-30).
5. Beutels, P. (1998, Nov). Economic evaluations applied to HB vaccination: General observations. Vaccine 16(Suppl):S84-S92.
6. Beutner, K. R., and Tyring, S. (1997, May 5). Human papillomavirus and human disease. Am. J. Med. 102(5A):9-15. (Review).
7. Bosch, F. X., Lorincz, A., Muñoz, N., Meijer, C. J. L. M., and Shah, K. V. (2002). The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 55:244-265.
8. Bray, F., Loos, A. H., McCarron, P., Weiderpass, E., Arbyn, M., Møller, H., Hakama, M., and Parkin, D. M. (2005). Trends in cervical squamous cell carcinoma incidence in 13 European countries: Changing risk and the effects of screening. Cancer Epidemiol. Biomarkers Prev. 14:677-686.
9. Calvo, N., Morice, A., Saenz, E., and Navas, L. (2004, Aug) Using surveys of schoolchildren to evaluate coverage with and oppurtunity for vaccination in Costa Rica. Rev. Panam. Salud Publica. 16(2):118-124.
10. Clements, C. J., Chandra-Mouli, V., Byass, P., Ferguson, B. J. (1999). Global strategies, policies and practices for immunization of adolescents. http://www.who.int/vaccinesdocuments/DocsPDF/www9866.pdf
11. De Villiers, E. M., Fauquet, C., Broker, T. R., Bernard, H. U., and Zur Hausen, H. (2004, Jun. 20). Classification of papillomaviruses. Virology 324(1):17-27.
12. Dorn, H. F., and Cutler, S. J. (1959). Morbidity from cancer in the United States: Parts I and II. Publ. Health Monogr No. 56. US Dept of Health, Education and Welfare, Washington, D. C.
13. Fenner, F. (1982, Sep-Oct). A successful eradication campaign. Global eradication of smallpox. Rev Infect Dis. 4(5):916-930.
14. Ferlay, J., Bray, F., Pisani, P., and Parkin, D. M. (2004). GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. Lyon: IARC Press.
15. Fernandez Garrote, L., Lence Anta, J. J., Cabezas Cruz, E., Romero, T., and Camacho, R. (1996). Evaluation of the cervical cancer control program in Cuba. Bull. Pan Am. Health Organ. 30:387-391.
16. Follen, M., Meyskens, F. L. Jr., Alvarez, R. D., Walker, J. L., Bell, M. C., Storthz, K. A., Sastry, J., Roy, K., Richards-Kortum, R., and Cornelison, T. L. (2003, Nov. 1). Cervical cancer chemoprevention, vaccines, and surrogate endpoint biomarkers. Cancer 98(9 Suppl):2044-2051.
17. Franceschi, S., Dal Maso, L., Arniani, S., Crosignani, P., Vercelli, M., Simonato, L., Falcini, F., Zanetti, R., Barchielli, A., Serraino, D., and Rezza, G. (1998). Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. Br. J. Cancer 78:966-970.
18. Franceschi, S., Muñoz, N., Snijders, P. J., and Walboomers, W. W. (1996). Human papillomavirus and cancers of the upper aerodigestive tract: A review of epidemiological and experimental evidence. Cancer Epidemiol. Biomarkers Prev. 5:567-575.
19. Frisch, M., Biggar, R. J., and Goedert, J. J. (2000). Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J. Natl. Cancer Inst. 92:1500-1510.
20. Fu, Y. S., Berek, J. S., and Hilborne, L. H. (1987). Diagnostic problems of in situ and invasive adenocarcinomas of the uterine cervix. Appl. Pathol. 5:47-56.
21. Galloway, D. A. (2003, Aug). Papillomavirus vaccines in clinical trials. Lancet Infect Dis. 3(8):469-475.
22. Gillison, M. L., and Shah, K. V. (2001). Human papillomavirus-associated head and neck squamous cell carcinoma: Mounting evidence for an etiologic role for HPV in a subset of head and neck cancers. Curr. Opin. Oncol. 13:183-188.
23. Goedert, J. J., Cote, T. R., Virgo, P., Scoppa, S. M., Kingma, D. W., Gail, M. H., Jaffe, E. S., and Biggar, R. J. (1998). Spectrum of AIDS-associated malignant disorders. Lancet 351:1833-1839.
24. Goldie, S. J., Kim, J. J., and Wright, T. C. (2004b, Apr). Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more. Obstet. Gynecol. 103(4):619-631.
25. Goldie, S. J., Kohli, M., Grima, D., Weinstein, M. C., Wright, T. C., Bosch, F. X., and Franco, E. (2004a, Apr. 21). Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J. Natl. Cancer Inst. 96(8):604-615.
26. Grulich, A. E., Wan, X., Law, M. G., Coates, M., and Kaldor, J. M. (1999). Risk of cancer in people with AIDS. AIDS. 13:839-843.
27. Gustafsson, L., Ponten, J., Bergstrom, R., and Adami, H.-O. (1997a). International incidence rates of invasive cervical cancer before cytological screening. Int. J. Cancer 71:159-165.
28. Gustafsson, L., Ponten, J., Zack, M., and Adami, H.-O. (1997b). International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 8:755-763.
29. Hakama, M. (1982). Trends in the incidence of cervical cancer in the Nordic countries. In K. Magnus (ed.): Trends in Cancer Incidence, pp. 279-292. New York: Hemisphere Press.
30. Harper, D. M., Franco, E. L., Wheeler, C., Ferris, D. G., Jenkins, D., Schuind, A., Zahaf, T., Innis, B., Naud, P., De Carvalho, N. S., Roteli-Martins, C. M., Teixeira, J., Blatter, M. M., Korn, A. P., Quint, W., Dubin, G., and the GlaxoSmithKline HPV Vaccine Study Group. (2004, Nov. 13). Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomised controlled trial. Lancet 364(9447):1757-1765.
31. Harro, C. D., Pang, Y. Y., Roden, R. B., Hildesheim, A., Wang, Z., Reynolds, M. J., Mast, T. C., Robinson, R., Murphy, B. R., Karron, R. A., Dillner, J., Schiller, J. T., and Lowy, D. R. (2001, Feb. 21). Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J. Natl. Cancer Inst. 93(4):284-292
32. Heymann, D. L., and Aylward, R. B. (2004, Sep. 23). Eradicating polio. N. Engl. J. Med. 351(13):1275-1277.
33. Herrero, R., Brinton, L. A., Reeves, W. C., Brenes, M. M., De Britton, R. C., Gaitan, E., and Tenorio, F. (1992). Screening for cervical cancer in Latin America: A case-control study. Int. J. Epidemiol. 21:1050-1056.
34. Herrero, R., Muñoz, N., Lazcano, E., Poss, H., Sukvirach, S., De Sanjose, S., Meijer, C. J. L. M., Coursaget, P., and Walboomers, J. M. M. (2000). HPV International prevalence surveys in general populations. Proc. 18th Int. Papillomavirus Conf., Barcelona, O54, p. 126.
35. Herrero, R., and Munoz, N. (1999). Human papillomavirus and cancer. In R. Newton, V. Beral & R. Weiss (eds.): Infections & Human Cancer, Cancer Surveys, vol. 33. pp. 75-98.
36. Herrero, R., Hildesheim, A., Bratti, C., Sherman, M. E., Hutchinson, M., Morales, J., Balmaceda, I., Greenberg, M. D., Alfaro, M., Burk, R. D., Wacholder, S., Plummer, M., and Schiffman, M. (2000a). Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J. Natl. Cancer Inst. 92:464-474.
37. Herrero, R., Castellsagué, X., Pawlita, M., Lissowska, J., Kee, F., Balaram, P., Rajkumar, T., Sridhar, H., Rose, B., Pintos, J., Fernandez, L., Idris, A., Nieto, M. J., Nieto, A., Talamini, R., Tavani, A., Bosch, X., Riedel, U., Snijders, P. J. F., Meijer, C. J. M., Viscidi, R., Muñoz, N., and Franceschi, S. for the IARC Multi-centric Oral Cancer Study Group. (2003). Human papillomavirus and oral cancer: The International Agency for Research on Cancer multicenter study. J. Natl. Cancer Inst. 95:1772-1783.
38. Hildesheim, A., Schiffman, M., Scott, D. R., Marti, D., Kissner, T., Sherman, M. E., Glass, A. G., Manos, M. M., Lorincz, A. T., Kurman, R. J., Buckland, J., Rush, B. B., and Carrington, M. (1998a, Nov). Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: Results from a casecontrol study conducted in the United States. Cancer Epidemiol. Biomarkers Prev. 7(11):1035-1041.
39. Hildesheim, A., Schiffman, M., Brinton, L. A., Fraumeni, J. F. Jr., Herrero, R., Bratti, M. C., Schwartz, P., Mortel, R., Barnes, W., Greenberg, M., McGowan, L., Scott, D. R., Martin, M., Herrera, J. E., and Carrington, M. (1998b, Dec. 10). p53 polymorphism and risk of cervical cancer. Nature 396 (6711). 531-532.
40. Hildesheim, A., Herrero, R., Castle, P. E., Wacholder, S., Bratti, M. C., Sherman, M. E., Lorincz, A. T., Burk, R. D., Morales, J., Rodriguez, A. C., Helgesen, K., Alfaro, M., Hutchinson, M., Balmaceda, I., Greenberg, M., and Schiffman, M. (2001). HPV cofactors related to the development of cervical cancer: Results from a population-based study in Costa Rica. Br. J. Cancer 84:1219-1226.
41. Hill, A. B. (1965). The environment and disease: Association or causation?. Proc. R. Soc. Med. 58, 295-300.
42. Hippelainen, M. I., Syrjanen, S., Hippelainen, M. J., Saarikoski, S., and Syrjanen, K. (1993, Oct). Diagnosis of genital human papillomavirus (HPV) lesions in the male: Correlation of peniscopy, histology and in situ hybridisation. Genitourin Med. 69(5):346-351.
43. Ho, G. Y., Studentsov, Y., Hall, C. B., Bierman, R., Beardsley, L., Lempa, M., and Burk, R. D. (2002, Sep. 15). Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles. J. Infect. Dis. 186(6):737-742.
44. Ho, G. Y., Bierman, R., Beardsley, L., Chang, C. J., and Burk, R. D. (1998). Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338:423-428.
45. Hughes, J. P., Garnett, G. P., and Koutsky, L. (2002). The theoretical population-level impact of a prophylactic human papillomavirus vaccines. Epidemiology. 13(6):631-639.
46. IARC. (1995). Monographs on the Evaluation of Carcinogenic Risks to Humans. Human Papillomaviruses, vol. 64. Lyon: IARC Press.
47. IARC. (2004a). Monographs on the Evaluation of Carcinogenic Risks to Humans. Tobacco Smoke and Involuntary Smoking, vol. 83. Lyon: IARC Press.
48. IARC. (2004b). Handbooks of Cancer Prevention Vol. 10. Cervical Cancer Screening. Lyon: IARC Press.
49. Jayant, K., Rao, R. S., Nene, B. M., and Dale, P. S. (1995). Improved stage at diagnosis of cervical cancer with increased cancer awareness in a rural Indian population. Int. J. Cancer 63, 161-163.
50. Jin, F., Devesa, S. S., Chow, W. H., Zheng, W., Ji, B. T., Fraumeni, J. F. Jr., and Gao, Y. T. (1999). Cancer incidence trends in urban Shanghai, 1972-1994: An update. Int. J. Cancer 83:435-440.
51. Koutsky, L. A., Holmes, K. K., Critchlow, C. W., Stevens, C. E., Paavonen, J., Beckmann, A. M., De Rouen, T. A., Galloway, D. A., Vernon, D., and Kiviat, N. B. (1992, Oct. 29). A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N. Engl. J. Med. 327(18):1272-1278.
52. Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., and Jansen, K. U. (2002). A controlled trial of a human papillomavirus type 16 vaccine. N. Engl. J. Med. 347:1645-1651.
53. Koutsky, L. A., and Kiviat, N. B. (1999). Human papillomavirus infections. In K. K. Holmes, P. F. Sparling P. A. Mardh, S. M. Lemon, W. E. Stamm, P. Piot, and J. N. Wasserheit (eds.): Sexually transmitted Diseases. 3rd ed. New York: McGraw-Hill, pp. 347-360.
54. Koutsky, L. A., Galloway, D. A., and Holmes, K. K. (1988). Epidemiology of genital human papillomavirus infection. Epidemiol. Rev. 10:122-163 (Review).
55. Koutsky, L. A. (1997, May 5). Epidemiology of genital human papillomavirus infection. Am. J. Med. 102(5A):3-8 (Review).
56. Lazcano-Ponce, E., Alonso, P., Lopez, L., and Hernandez, M. (1994). Quality control study on negative gynaecological cytology in Mexico. Diagn. Cytopathol. 10:10-14.
57. Lazcano-Ponce, E. C., Buiatti, E., Najera-Aguilar, P., Alonso-de-Ruiz, P., and Hernandez-Avila, M. (1998). Evaluation model of the Mexican national program for early cervical cancer detection and proposals for a new approach. Cancer Causes Control 9:241-251.
58. Ley, C., Bauer, H. M., Reingold, A., Schiffman, M. H., Chambers, J. C., Tashiro, C. J., and Manos, M. M. (1991). Determinants of genital human papillomavirus infection in young women. J. Natl. Cancer Inst. 83:997-1003.
59. Li, H. Q., Jin, S. Q., Xu, H. X., and Thomas, D. B. (2000). The decline in the mortality rates of cervical cancer and a plausible explanation in Shandong, China. Int. J. Epidemiol. 29(3):398-404.
60. Lörincz, A. T. (1997). Methods of DNA Hybridization and their Clinical Applicability to Human Papillomavirus Detection. In E. Franco and J. Monsonego (eds.): New Developments in Cervical Cancer Screening and Prevention. Chapter 37, pp. 325-337. UK: Blackwell Science.
61. Mandelblatt, J. S., Kanetsky, P., Eggert, L., and Gold, K. (1999). Is HIV infection a cofactor for cervical squamous cell neoplasia?. Cancer Epidemiol. Biomarkers Prev. 8:97-106.
62. Manhart, L. E., and Koutsky, L. A. (2002, Nov). Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm. Dis. 29(11):725-735.
63. Martinez, J., Smith, R., Farmer, M., Resau, J., Alger, L., Daniel, R., Gupta, J., Shah, K., and Naghashfar, Z. (1988, Oct). High prevalence of genital tract papillomavirus infection in female adolescents. Pediatrics 82(4):604-608.
64. Miller, A. B. (1992). Cervical Cancer Screening Programs. Managerial Guidelines. World Health Organization, Geneva, Switzerland.
65. Moreno, V., Bosch, F. X., Muñoz, N., Meijer, C. J., Shah, K. V., Walboomers, J. M., Herrero, R., and Franceschi, S. (2002). Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: The IARC multicentric casecontrol study. Lancet 359:1085-1092.
66. Moscicki, A. B., Shiboski, S., Broering, J., Powell, K., Clayton, L., Jay, N., Darragh, T. M., Brescia, R., Kanowitz, S., Miller, S. B., Stone, J., Hanson, E., and Palefsky, J. (1998). The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J. Pediatr. 132:277-284.
67. Muñoz, N., Bosch, F. X., De Sanjose, S., Vergara, A., Del Moral, A., Munoz, M. T., Tafur, L., Gili, M., Izarzugaza, I., Viladiu, P., Navarro, C., Alonso De Ruiz, P., Aristizabal, N., Sanatamaria, M., Orfilla, J., Daniel, R. E., Guerrero, E., and Shah, K. V. (1993). Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol. Biomarkers Prev. 2:423-431.
68. Muñoz, N., Franceschi, S., Bosetti, C., Moreno, V., Herrero, R., Smith, J. S., Shah, K. V., Meijer, C. J., and Bosch, F. X. (2002). Role of parity and human papillomavirus in cervical cancer: The IARC multicentric case-control study. Lancet 359:1093-1101.
69. Muñoz, N., Bosch, F. X., Castellsague, X., Diaz, M., De Sanjose, S., Hammouda, D., Shah, K. V., and Meijer, C. J. (2004). Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int. J. Cancer 111:278-285.
70. Odunsi, K., Terry, G., Ho, L., Bell, J., Cuzick, J., and Ganesan, T. S. (1996). Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles. Int. J. Cancer 67:595-602.
71. Pagliusi, S. P., and Aguado, M. T. (2004). Efficacy and other milestones for human papillomavirus vaccine introduction. Vaccine. 23(5):569-578.
72. Papanicolaou, G. N., and Traut, H. F. (1943). Diagnosis of Uterine Cancer by the Vaginal Smear. New York: Commonwealth Fund.
73. Parkin, D. M., Ferlay, J., Handi-Cherif, M., Sitas, F., Thomas, J. O., Wabinga, H., and Whelan, S. L. (2003). Cancer in Africa: Epidemiology and Preventuion. IARC Scientific publication No. 153, Lyon: IARC Press.
74. Parkin, D. M., Bray, F., Ferlay, J., and Pisani, P. (2005). Global Cancer Statistics 2002. CA Cancer J Clin. 55:74-108.
75. Parkin, D. M., Whelan, S. L., Ferlay, J., Teppo, L., and Thomas, D. B. (eds.). (2002). Cancer Incidence in Five Continents, vol. VIII, IARC Scientific Publications No. 155, Lyon: IARC Press.
76. Pham, T. H., Nguyen, T. H., Herrero, R., Vaccarella, S., Smith, J. S., Nguyen Thuy, T. T., Nguyen, H. N., Nguyen, B. D., Ashley, R., Snijders, P. J., Meijer, C. J., Muñoz, N., Parkin, D. M., and Franceschi, S. (2003). Human papillomavirus infection among women in South and North Vietnam. Int. J. Cancer 104, 213-220.
77. Pfister, H. (2003). Human papillomavirus and skin cancer. Chapter 8. J Natl. Cancer Inst. Monogr. 31:52-56.
78. Pontén, J., Adami, H. O., Bergström, R., Dillner, J., Friberg, L. G., Gustafsson, L., Miller, A. B., Parkin, D. M., Sparén, P., and Trichopoulos, D. (1995). Strategies for global control of cervical cancer. Int. J. Cancer 60, 1-26.
79. Quinn, M., Babb, P., Jones, J., and Allen, E. (1999). Effect of screening on incidence of and mortality from cancer of cervix in England: Evaluation based on routinely collected statistics. Br. Med. J. 318:904-908.
80. Sadjadi, A., Malekzadeh, R., Derakhshan, M. H., Sepehr, A., Nouraie, M., Sotoudeh, M., Yazdanbod, A., Shokoohi, B., Mashayekhi, A., Arshi, S., Majidpour, A., Babaei, M., Mosavi, A., Mohagheghi, M. A., Alimohammadian, M., and Mohagheghi Mosavi, M. A. (2003). Cancer occurrence in Ardabil: Results of a population-based cancer registry from Iran. Int. J. Cancer 107:113-118.
81. De Sanjose, S., Muñoz, N., Bosch, F. X., Reimann, K., Pedersen, N. S., Orfila, J., Ascunce, N., Gonzalez, L. C., Tafur, L., Gili, M., Lette, I., Viladiu, P., Tormo, M. J., Moreo, P., Shah, K., and Wahren, B. (1994). Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int. J. Cancer 56:358-363.
82. Sankaranarayanan, R., Basu, P., Wesley, R. S., Mahé, C., Keita, N., Gombe Mbalawa, C. C., Sharma, R., Dolo, A., Shastri, S. S., Nacoulma, M., Nayama, M., Somanathan, T., Lucas, E., Muwonge, R., Frappart, L., and Parkin, D. M. (2004). Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentric study in India and Africa. Int. J. Cancer 110, 907-913.
83. Sellors, J. W., and Sankaranarayanan, R. (2003). Colposcopy and Treatment Of Cervical Intraepithelial Neoplasia: A Beginners Manual. Lyon: IARC Press.
84. Serraino, D., Carrieri, P., Pradier, C., Bidoli, E., Dorrucci, M., Ghetti, E., Schiesari, A., Zucconi, R., Pezzotti, P., Dellamonica, P., Franceschi, S., and Rezza, G. (1999). Risk of invasive cervical cancer among women with or at risk for HIV infection. Int. J. Cancer 82:334-337.
85. Shah, K. V. (1998). Do human papillomavirus infections cause oral cancer?. J. Natl. Cancer Inst. 90:1585-1586
86. Shin, H. R., Franceschi, S., Vaccarella, S., Roh, J. W., Ju, Y. H., Oh, J. K., Kong, H. J., Rha, S. H., Jung, S. I., Kim, J. I., Jung, K. Y., Van Doorn, L. J., and Quint, W. (2004, Aug. 1). Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J. Infect. Dis. 190(3):468-476.
87. Sigurdsson, K. (1995). Quality assurance in cervical cancer screening: The Icelandic experience 1964-1993. Eur. J. Cancer 31A:728-734.
88. Sigurdsson, K. (1999). The Icelandic and Nordic cervical screening programs: Trends in incidence and mortality rates through 1995. Acta Obstet. Gynecol. Scand. 78:478-485.
89. Smith, J. S., Muñoz, N., Herrero, R., Eluf-Neto, J., Ngelangel, C., Franceschi, S., Bosch, F. X., Walboomers, J. M., and Peeling, R. W. (2002). Evidence for Chlamydia trachomatis as an HPV cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J. Infect Dis. 185:324-331.
90. Snijders, P. J. F., Steenbergen, R. D. M., Meijer, C. J. L. M., and Walboomers, J. M. M. (1997). Role of human papillomaviruses in cancer of the respiratory and upper digestive tract. Clin. Dermatol. 15:415-425.
91. Snijders, P. J., Van Den Brule, A. J., and Meijer, C. J. (2003). The clinical relevance of human papillomavirus testing: Relationship between analytical and clinical sensitivity. J. Pathol. 201:1-6.
92. Sobhani, I., Walker, F., Roudot-Thoraval, F., Abramowitz, L., Johanet, H., Henin, D., Delchier, J. C., and Soule, J. C. (2004). Anal carcinoma: Incidence and effect of cumulative infections. AIDS. 18:1561-1569.
93. Stjernsward, J., Eddy, D., Luthra, U. K., and Stanley, K. (1987). Plotting a new course for cervical cancer screening in developing countries. World Health Forum. 8:42-45.
94. Syrjanen, S. M. (1990). Basic concepts and practical applications of recombinant DNA techniques in detection of human papillomavirus (HPV) infection. APMIS. 98:95-110.
95. Taira, A. V., Neukermans, C. P., and Sanders, G. D. (2004). Evaluating Human Papillomavirus vaccination programs. Emerging Infect. Dis. 10:1915-1923. (See also http://www.cdc.gov/eid)
96. Thomas, D. B., Qin, Q., Kuypers, J., Kiviat, N., Ashley, R. L., Koetsawang, A., Ray, R. M., and Koetsawang, S. (2001). Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive cervical carcinomas. Am. J. Epidemiol. 153:732-739.
97. Ursin, G., Peters, R. K., Henderson, B. E., D'Ablaing, G., III, Monroe, K. R., and Pike, M. C. (1994). Oral contraceptive use and adenocarcinoma of cervix. Lancet 344:1390-1394.
98. Vandelaer, J., Birmingham, M., Gasse, F., Kurian, M., Shaw, C., and, Garnier, S. (2003 Jul. 28). Tetanus in developing countries: An update on the Maternal and Neonatal Tetanus Elimination Initiative. Vaccine 21:3442-3445.
99. Van Houten, V. M. M., Snijders, P. J. F., Van Den Brekel, M. W. M., Kummer, J. A., Meijer, C. J. L. M., Van Leeuwen, B., Denkers, F., Smeele, L. E., Snow, G. B., and Brakenhoff, R. H. (2001). Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int. J. Cancer 93:232-235.
100. Vizcaino, A. P., Moreno, V., Bosch, F. X., Muñoz, N., Barros-Dios, X. M., and Parkin, D. M. (1998). International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int. J. Cancer 75:536-545.
101. Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., Snijders, P. J., Peto, J., Meijer, C. J., and Muñoz, N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. (1999). J. Pathol. 189:12-19.
102. Winer, R. L., Lee, S. K., Hughes, J. P., Adam, D. E., Kiviat, N. B., and Koutsky, L. A. (2003). Genital human papillomavirus infection: Incidence and risk factors in a cohort of female university students. Am. J. Epidemiol. 157:218-226.
103. Woodman, C. B., Collins, S., Winter, H., Bailey, A., Ellis, J., Prior, P., Yates, M., Rollason, T. P., and Young, L. S. (2001). Natural history of cervical human papillomavirus infection in young women: A longitudinal cohort study. Lancet 357:1831-1836.
104. Yang, L., Li, L. D., Chen, T. D., and Parkin, D. M. (2003). Time Trends in Cancer Mortality in China:1987-1999. Int. J. Cancer 106:771-783.
105. Zur Hausen, H. (2002). Papillomaviruses and cancer: From basic studies to clinical application. Natl. Rev. Cancer 2:342-350.
106. Zur Hausen, H. (2000). Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis. J. Natl. Cancer Inst. 3. 92(9):690-698.
107. Zur Hausen, H. (1976). Condylomata acuminata and human genital cancer. Cancer Res. 36(2 pt):794.